Nebulized Morphine in Chest Trauma Patients: A Prospective Study

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 14, 2018

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
Blunt Injury of Thorax
Interventions
DRUG

Morphine (+)

"We performed a first nebulization of 10 mg (1mL) of morphine diluted in 4 mL of normal saline using a nebulizer with an oxygen flow rate of 8 L / min. The quality of analgesia was assessed by VAS at rest and cough after 10 minutes. If ≤ 4, we concluded to a success. If VAS was still\> 4, a second nebulization was performed. After 20 minutes, if VAS still higher than 4 we performed a third nebulization. If pain level was ≤ 4, we concluded to a success. After 30 minutes, if VAS still\> 4, we concluded to a failure of morphine nebulization.~The patients were divided into two groups:~morphine (+) group: good response to morphine in nebulization morphine (-) group: failure of morphine in nebulization"

Trial Locations (1)

5180

Mahdia Hospital, Mahdia

All Listed Sponsors
lead

University Hospital, Mahdia

OTHER

NCT03580187 - Nebulized Morphine in Chest Trauma Patients: A Prospective Study | Biotech Hunter | Biotech Hunter